AdaptHealth director granted 18,999 RSUs

AdaptHealth Corp. director Dale B. Wolf reported a compensation-related equity award and updated holdings.

Rhea-AI Filing Summary

AdaptHealth Corp. director Dale B. Wolf reported a compensation-related equity award and updated holdings. He received 18,999 shares of common stock as a grant or award, at a stated price of $0.00 per share, structured as restricted stock units that will settle in common stock upon vesting. After this grant, he directly holds 123,234 shares. Separately, 14,000 shares are held indirectly by the Dale B. Wolf Generation Skipping Trust, for which he is the investment manager. No option exercises, open-market buys, or sales are shown in this filing, making the activity primarily a routine equity compensation update and ownership report.

Insider Trade Summary

Grant/Award: 18,999 shares

Grant/Award 2 txns

Insider WOLF DALE B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	18,999	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 123,234 shares (Direct); Common Stock — 14,000 shares (Indirect, By Trust)

Footnotes (2)

1. F1. These shares represent restricted stock units and will be settled in common stock upon vesting.
2. F2. Securities held by the Dale B. Wolf Generation Skipping Trust (the "GST"). The reporting person is the investment manager of the GST.

Key Figures

Equity grant: 18,999 shares Grant price: $0.00 per share Direct holdings after grant: 123,234 shares +1 more

4 metrics

Equity grant 18,999 shares Restricted stock units granted on June 24, 2026

Grant price $0.00 per share Stated price for RSU award

Direct holdings after grant 123,234 shares Common stock directly owned following the transaction

Indirect trust holdings 14,000 shares Common stock held by the Dale B. Wolf Generation Skipping Trust

Key Terms

restricted stock units, Generation Skipping Trust, indirect ownership

3 terms

restricted stock units financial

"These shares represent restricted stock units and will be settled in common stock upon vesting."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Generation Skipping Trust financial

"Securities held by the Dale B. Wolf Generation Skipping Trust (the "GST")."

indirect ownership financial

"direct_or_indirect: "I", nature_of_ownership: "By Trust""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AdaptHealth (AHCO) director Dale B. Wolf report?

Dale B. Wolf reported receiving 18,999 shares of AdaptHealth common stock as a grant or award. These shares are represented by restricted stock units that will settle in common stock upon vesting, reflecting routine equity-based compensation rather than an open-market purchase.

How many AdaptHealth (AHCO) shares does Dale B. Wolf hold after this Form 4?

After the reported grant, Dale B. Wolf directly holds 123,234 shares of AdaptHealth common stock. In addition, 14,000 shares are held indirectly through the Dale B. Wolf Generation Skipping Trust, where he serves as investment manager, giving a fuller picture of his reported ownership.

Was the AdaptHealth (AHCO) Form 4 transaction an open-market buy or sale?

The Form 4 does not show any open-market buys or sales. Instead, it reports a grant or award of 18,999 restricted stock units at a stated price of $0.00 per share, which is typical for equity compensation and not a market transaction.

What is the role of the Dale B. Wolf Generation Skipping Trust in AHCO holdings?

The filing shows 14,000 AdaptHealth shares held by the Dale B. Wolf Generation Skipping Trust. The footnote explains that the reporting person is the investment manager of this trust, so these shares are reported as indirect ownership associated with his overall position.

How are the 18,999 AdaptHealth (AHCO) shares structured in Dale B. Wolf’s grant?

The 18,999 shares are described as restricted stock units that will be settled in AdaptHealth common stock upon vesting. This means he earns actual shares over time as vesting conditions are met, aligning compensation with longer-term company performance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 04:04 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WOLF DALE B

(Last) (First) (Middle)

C/O ADAPTHEALTH LLC

555 EAST NORTH LANE, SUITE 5075

(Street)

CONSHOHOCKEN PENNSYLVANIA 19428

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/24/2026		A		18,999	A	$0(1)	123,234	D
Common Stock								14,000	I	By Trust(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares represent restricted stock units and will be settled in common stock upon vesting.

2. Securities held by the Dale B. Wolf Generation Skipping Trust (the "GST"). The reporting person is the investment manager of the GST.

Remarks:

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on June 30, 2025 as an exhibit to the Form 4 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.

	/s/ Richard Rew, as attorney-in-fact for Dale Wolf	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)